Rifagut (Rifaximin 200 mg)
Brand name:
Rifagut
Generic name:
Rifaximin
Actual product may differ in appearance from image shown.
Rifagut is a trusted brand of Rifaximin, a gut-focused antibiotic designed to work mainly inside the intestines with minimal absorption into the bloodstream. It is commonly used to help manage traveler diarrhea caused by noninvasive E. coli and is also widely prescribed to support symptom control in irritable bowel syndrome with diarrhea (IBS-D). In liver care, rifaximin is often used to reduce the risk of recurrent hepatic encephalopathy by lowering ammonia-producing intestinal bacteria.
This medication is valued for its targeted local action, which may lead to fewer systemic side effects compared with many broad-spectrum antibiotics.
Generic Rifagut can be an effective option when you need a treatment that focuses on the digestive tract while helping restore day to day comfort. Always follow the prescribed regimen, avoid unnecessary antibiotic use, and seek medical advice if symptoms are severe, persistent, or include high fever or blood in stool.
Manufacturer:
Active ingredients:
Rifagut is a gut targeted antibiotic containing the active ingredient rifaximin (chemical formula C43H51N3O11), designed to act locally in the intestines with minimal systemic absorption, helping control harmful intestinal bacteria, support digestive balance, and reduce symptoms associated with traveler diarrhea, IBS-D, and hepatic encephalopathy while maintaining a favorable safety profile.
Indications:
- Travelers Diarrhea (noninvasive E. coli): Treatment of acute infectious diarrhea acquired during travel;
- Irritable Bowel Syndrome with Diarrhea (IBSD): Reduction of chronic diarrhea, bloating, and abdominal pain;
- Hepatic Encephalopathy (prevention of recurrence): Decreases ammonia-producing intestinal bacteria in patients with liver cirrhosis;
- Small Intestinal Bacterial Overgrowth (SIBO): Off-label use to reduce excessive bacterial growth in the small intestine;
- Chronic Infectious Diarrhea: Management of persistent bacterial diarrhea when localized gut action is required;
- Diverticular Disease (symptom control): Adjunct therapy to reduce intestinal bacterial load and inflammation;
- Inflammatory Bowel Disease – adjunct use: Supportive treatment in selected cases to control bacterial imbalance;
- Prevention of Postoperative Intestinal Infections: Reduction of intestinal bacteria before or after gastrointestinal surgery.
- Irritable Bowel Syndrome with Diarrhea (IBSD): Reduction of chronic diarrhea, bloating, and abdominal pain;
- Hepatic Encephalopathy (prevention of recurrence): Decreases ammonia-producing intestinal bacteria in patients with liver cirrhosis;
- Small Intestinal Bacterial Overgrowth (SIBO): Off-label use to reduce excessive bacterial growth in the small intestine;
- Chronic Infectious Diarrhea: Management of persistent bacterial diarrhea when localized gut action is required;
- Diverticular Disease (symptom control): Adjunct therapy to reduce intestinal bacterial load and inflammation;
- Inflammatory Bowel Disease – adjunct use: Supportive treatment in selected cases to control bacterial imbalance;
- Prevention of Postoperative Intestinal Infections: Reduction of intestinal bacteria before or after gastrointestinal surgery.
Benefits:
- Localized intestinal action: Works mainly in the gut, targeting harmful bacteria where the problem originates;
- Minimal systemic absorption: Reduces exposure to the whole body and lowers the risk of systemic side effects;
- Effective symptom control: Helps relieve diarrhea, bloating, and abdominal discomfort;
- Gut microbiota modulation: Supports a healthier balance of intestinal bacteria without broad systemic disruption;
- Lower resistance risk: Limited absorption may reduce the development of widespread antibiotic resistance;
- Good tolerability profile: Generally well tolerated when used as prescribed;
- Convenient oral therapy: Easy to administer without injections or hospital procedures.
- Minimal systemic absorption: Reduces exposure to the whole body and lowers the risk of systemic side effects;
- Effective symptom control: Helps relieve diarrhea, bloating, and abdominal discomfort;
- Gut microbiota modulation: Supports a healthier balance of intestinal bacteria without broad systemic disruption;
- Lower resistance risk: Limited absorption may reduce the development of widespread antibiotic resistance;
- Good tolerability profile: Generally well tolerated when used as prescribed;
- Convenient oral therapy: Easy to administer without injections or hospital procedures.
Analogs:
Alfa Normix, Colidur, Flonorm, Laxiriva, Normix, Rifaxan, Rifagut, Rifaximin Tablets, Xifaxan.